Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Cataract Global Clinical Trials Review, H1

Cataract Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Cataract Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Cataract Global Clinical Trials Review, H1, 2015" provides an overview of Cataract clinical trials scenario. This report provides top line data relating to the clinical trials on Cataract. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Cataract 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Cataract to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Cataract to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Cataract 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Cataract Therapeutics Clinical Trials 31

Prominent Drugs 32

Latest Clinical Trials News on Cataract 33

Apr 20, 2015: Icon Bioscience Announces Pivotal Phase 3 Clinical Data Demonstrates Exceptional Efficacy of IBI-10090 in Reducing Inflammation Associated with Cataract Surgery 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

Valeant Pharmaceuticals International, Inc. 34

Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 34

Novartis AG 36

Clinical Trial Overview of Novartis AG 36

Innovative Medical Products 38

Clinical Trial Overview of Innovative Medical Products 38

Actavis plc 39

Clinical Trial Overview of Actavis plc 39

Laboratoires Thea S.A. 40

Clinical Trial Overview of Laboratoires Thea S.A. 40

InSite Vision Incorporated 41

Clinical Trial Overview of InSite Vision Incorporated 41

Bucci Laser Vision 42

Clinical Trial Overview of Bucci Laser Vision 42

Omeros Corporation 43

Clinical Trial Overview of Omeros Corporation 43

Bausch & Lomb Incorporated 44

Clinical Trial Overview of Bausch & Lomb Incorporated 44

Abbott Laboratories 45

Clinical Trial Overview of Abbott Laboratories 45

Clinical Trial Overview of Top Institutes / Government 46

NHS Trusts Clinical Trials 46

Clinical Trial Overview of NHS Trusts Clinical Trials 46

Indiana University School of Medicine 47

Clinical Trial Overview of Indiana University School of Medicine 47

Moorfields Eye Hospital NHS Foundation Trust 48

Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust 48

Department of Health, UK 49

Clinical Trial Overview of Department of Health, UK 49

National Eye Institute 50

Clinical Trial Overview of National Eye Institute 50

All India Institute of Medical Sciences 51

Clinical Trial Overview of All India Institute of Medical Sciences 51

Arak University of Medical Sciences 52

Clinical Trial Overview of Arak University of Medical Sciences 52

Capital Medical University 53

Clinical Trial Overview of Capital Medical University 53

Federal University of Sao Paulo 54

Clinical Trial Overview of Federal University of Sao Paulo 54

Het Oogziekenhuis Rotterdam 55

Clinical Trial Overview of Het Oogziekenhuis Rotterdam 55

Five Key Clinical Profiles 56

Appendix 77

Abbreviations 77

Definitions 77

Research Methodology 78

Secondary Research 78

About GlobalData 79

Contact Us 79

Disclaimer 79

Source 79

List of Figures

Cataract Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Cataract Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cataract Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cataract Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Cataract Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Cataract Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Cataract Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Cataract Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Cataract to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Cataract Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Cataract Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Cataract to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Cataract Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Cataract Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Cataract Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Cataract Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Cataract Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Cataract Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Cataract Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Cataract Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Cataract Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Cataract Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Cataract Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 78

List of Tables

Cataract Therapeutics, Global, Clinical Trials by Region, 2015* 7

Cataract Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cataract Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cataract Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Cataract Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Cataract Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Cataract Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Cataract Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Cataract to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Cataract Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Cataract Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Cataract to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Cataract Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Cataract Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Cataract Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Cataract Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Cataract Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Cataract Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Cataract Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Cataract Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Cataract Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Cataract Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Cataract Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Cataract Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Cataract Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Cataract Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 34

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 36

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovative Medical Products, 2015* 38

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 39

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Thea S.A., 2015* 40

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by InSite Vision Incorporated, 2015* 41

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Bucci Laser Vision, 2015* 42

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Omeros Corporation, 2015* 43

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Bausch & Lomb Incorporated, 2015* 44

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 45

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Trusts Clinical Trials, 2015* 46

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2015* 47

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015* 48

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 49

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 50

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015* 51

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015* 52

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2015* 53

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 54

Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Het Oogziekenhuis Rotterdam, 2015* 55

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Valeant Pharmaceuticals International, Inc.

Novartis AG

Innovative Medical Products

Actavis plc

Laboratoires Thea S.A.

InSite Vision Incorporated

Bucci Laser Vision

Omeros Corporation

Bausch & Lomb Incorporated

Abbott Laboratories

Cataract Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Cataract, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com